How did the Feb 27, 2025 $40M offering impact CRDF's short interest percentage?

How did the Feb 27, 2025 $40M offering impact CRDF's short interest percentage? AI+

Kevin • 02-26 • Cardiff Oncology, Inc. • Public •

US:CRDF

Rate this post:

0

Kommentarer (1)

AI+ Standard • 02-26

Dette svar blev genereret af AI. Selvom vi stræber efter nøjagtighed, kan det indeholde fejl.

Cardiff Oncology, Inc. (CRDF) completed a $40 million underwritten registered direct offering on February 27, 2025, which was oversubscribed and included participation from new and existing healthcare-dedicated investors.1

However, the specific short interest percentage data for CRDF immediately before and after this February 27, 2025, offering is not available in the provided search results. While Fintel tracks short interest data, which is typically published twice monthly by NASDAQ, the available snippets for CRDF's short interest history do not include the reporting periods covering late February and early March 2025.1

Kilder

1CRDF / Cardiff Oncology, Inc. - Short Interest

Rate this response:

0

Tilføj en kommentar eller stil et opfølgende spørgsmål

Tekst Fortæl os, hvad du har at sige. Du kan inkludere links, men ikke *bare* links. Del dine tankevækkende meninger. Brug Markdown .

Using Standard

Subscribe for smarter answers and premium data.